Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

Clariant shares slip after chemicals group slashes annual sales target

Investing.com — Shares in Clariant (SIX:CLN) fell by more than 5% in early European trading on Tuesday after the Swiss chemicals group slashed its annual sales target and unveiled third-quarter profits that missed expectations.

Chief Executive Conrad Keijzer flagged the business has faced a “continued challenging environment” and broader uncertainties despite easing inflationary pressures. Chemical companies have been hit by higher energy prices and weaker customer demand, denting revenues.

Citing no prospect of a “significant economic recovery” this year, Clariant said it now expects to post a low single-digit percent decline in local currency sales in 2024. It had previously predicted that full-year sales would be flat or grow by up to the low single-digit percentage.

Growth in its absorbents and additives unit and care chemicals arm, which includes the recently-acquired Lucas Meyer Cosmetics, is also now tipped to “only partially offset” lower sales at its catalysts division.

But Clariant — the maker of products used to make items like de-icers and food ingredients — reiterated its guidance for 2024 earnings before interest, taxes, depreciation and amortization margin of around 16%. The firm noted the contribution of the Lucas Meyer purchase and a reduced impact from the closing of its Sunliquid bioethanol production in Romania helped counterbalance lower sales at its catalysts unit, which provides catalytic products for the chemical industry.

In 2025, Clariant added it projects “a year of continued improvement in profitability,” with sales growing by 3% to 5% and core income margin of 17% to 18%. The company said it “remains committed to its medium-term targets as end markets recover and growth normalizes over the next two to three years.”

For the third quarter, Clariant reported a 13% drop in core income versus the year-ago period to 139 million Swiss francs ($160.69 million) due in part to slipping catalysts segment volumes and restructuring costs. A company-compiled poll of analysts had called for 150 million Swiss francs.

“[D]emand in the business [is] also exposed to new capacity expansion in the industry, which is slowing due to the prevailing overcapacity,” analysts at JPMorgan Chase said in a note to clients.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com